CIDP disease, known as chronic inflammatory demyelinating polyneuropathy, is a disease that involves pain, numbing and weakness in the nerves, according to the American Association of Neuromuscular & Electrodiagnostic Medicine. The decline of the nerves and the surrounding tissue can be quite quick or can be slow with remission periods.
Many people who are diagnosed with chronic inflammatory demyelinating polyneuropathy disease will not be able to fully recover. Most people who get CIDP disease are between the ages of 50 to 70 and men are more likely to have the disease. In the United States, it is said that there are 1.5 to 3.6 million people who are suffering from CIDP disease in varying stages writes the American Association of Neuromuscular & Electrodiagnostic Medicine.
People who are suffering from CIDP disease experience symptoms such as the lack of deep tendon reflexes, tiredness, weakness in the extremities and strange sensations according to the National Institute of Neurological Disorders and Strokes. Once a patient has been diagnosed with the CIDP disease, doctors will work to prescribe corticosteroids and immunosuppressant drugs, such as prednisone. There will also be physiotherapy treatment modalities to help patients regain some of their strength and mobility. The prognosis for CIDP disease depends on the individual and can range from mild sensations in remission to loss of entire nerve axons.